The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests

Clin Endocrinol (Oxf). 1991 Feb;34(2):127-31. doi: 10.1111/j.1365-2265.1991.tb00282.x.

Abstract

The ability of several endocrine tests to distinguish between women with and without polycystic ovaries (PCO) has been studied prospectively in a series of 65 patients with functional oligo-amenorrhoea using ultrasonography as a reference test. In terms of overall diagnostic accuracy, the free androgen index (FAI) (94%) and the progestogen challenge (89%) gave similar results (Cl = -5 to 15%) but both were significantly better than all the other tests including measurement of serum LH (69%), total testosterone (71%) and androstenedione (74%) (minimum Cl = 6 to 23%). The FAI together with LH measurement was the most accurate of the combinations (97%) but this was not significantly better than the best of the combinations incorporating the progestogen challenge (92%; Cl = -3% to 13%). Given the limited availability of the assay for SHBG, these results show that assessment of oestrogen state is a useful method for categorizing patients with functional oligo-amenorrhoea.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amenorrhea / blood
  • Amenorrhea / etiology*
  • Androgens / blood
  • Androstenedione / blood
  • Female
  • Hair / growth & development
  • Humans
  • Luteinizing Hormone / blood
  • Oligomenorrhea / blood
  • Oligomenorrhea / etiology*
  • Polycystic Ovary Syndrome / blood
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / diagnosis*
  • Polycystic Ovary Syndrome / diagnostic imaging
  • Predictive Value of Tests
  • Progestins
  • Prospective Studies
  • Testosterone / blood
  • Ultrasonography

Substances

  • Androgens
  • Progestins
  • Testosterone
  • Androstenedione
  • Luteinizing Hormone